# OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate

> **NCT06273345** · — · RECRUITING · sponsor: **Istituto Oncologico Veneto IRCCS** · enrollment: 150 (estimated)

## Conditions studied

- Oligometastatic Prostate Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06273345
- **Lead sponsor:** Istituto Oncologico Veneto IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-23
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273345, "OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06273345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*